Institut Bergonié
Bordeaux
What changed
Study registered, no phase assigned: Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (METAGIST)
7mo agoTrial registeredDec 10, 2025Source filing (opens the source filing in a new tab)
Momentum
Momentum 71 out of 100, unchanged since the last recompute.
Accelerating: several high-weight events landed recently.
Runway (estimate)
No disclosed raise on file, so there is nothing to model from.
Stage
Phase I
The furthest-along thing in the public record. Not a projection.
Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.
Peer position
1,208 pre-ticker oncology companies at Phase I
Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.
Compare seatsA ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.
Grant to raise
Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.
- Trial
PHASE1 registered
Feb 1, 2015Solid Tumor, Osteosarcoma · COMPLETED · sponsor: Institut Bergonié · Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma
ClinicalTrials.gov · NCT02517918 (opens the source filing in a new tab)
- Trial
Study registered
Jan 5, 2008Metastatic Bone Tumor · COMPLETED · sponsor: Institut Bergonié · Patterns of Care and Outcomes in Patients With Metastatic Bone Tumors (METABONE)
ClinicalTrials.gov · NCT03963531 (opens the source filing in a new tab)
- Trial
Study registered
Jan 1, 1990Gastro Intestinal Stromal Tumor · COMPLETED · sponsor: Institut Bergonié · Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (METAGIST)
ClinicalTrials.gov · NCT03963544 (opens the source filing in a new tab)
Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources